SBC Medical Group Holdings Inc
SBCNasdaqCIK 1930313HealthcareFiscal year ends Dec 31
Reports and events: 88 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-07-2621:02 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-034470 |
| 2024-05-2016:17 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-020690 |
| 2024-05-0817:26 ET | 8-K | 3.01 Delisting notice | 0001493152-24-018277 |
| 2024-04-2316:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-015696 |
| 2024-04-0420:34 ET | 8-K | 3.01 Delisting notice | 0001493152-24-013078 |
| 2024-03-2119:14 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-014670 |
| 2024-03-1921:51 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-010402 |
| 2024-03-0117:22 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-008595 |
| 2024-02-2919:25 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-010505 |
| 2024-02-0809:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-005383 |
| 2024-02-0619:14 ET | SC 13D | Ownership report, active investor | 0001140361-24-005918 |
| 2024-01-2317:00 ET | DEF 14A | Proxy statementPeriod 2024-01-23 | 0001493152-24-003473 |
| 2024-01-1817:47 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-002794 |
| 2023-12-2918:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-046431 |
| 2023-11-1421:35 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-040695 |
| 2023-10-2617:26 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-038430 |
| 2023-09-1119:12 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-032156 |
| 2023-08-1416:19 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-028490 |
| 2023-06-2216:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-022132 |
| 2023-06-1616:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-021671 |
| 2023-06-0216:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-019965 |
| 2023-05-1916:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-018332 |
| 2023-05-1516:15 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-017364 |
| 2023-05-0916:49 ET | 8-K | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-015962 |
| 2023-05-0408:54 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-015382 |
| 2023-05-0120:14 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-014790 |
| 2023-04-2417:10 ET | DEF 14A | Proxy statementPeriod 2023-04-24 | 0001493152-23-013392 |
| 2023-03-0919:04 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001493152-23-007036 |
| 2023-02-0216:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-003426 |
| 2023-02-0107:30 ET | 8-K | 7.01 Regulation FD disclosure | 0001493152-23-003241 |
| 2022-11-1421:28 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001493152-22-031480 |
| 2022-09-2308:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-026617 |
| 2022-09-0916:00 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001493152-22-025487 |
| 2022-08-1716:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-023329 |
| 2022-08-0916:53 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-021781 |
| 2022-07-2519:22 ET | S-1/A | Registration statement, amended | 0001493152-22-020188 |
| 2022-07-2221:51 ET | S-1/A | Registration statement, amended | 0001493152-22-020076 |
| 2022-06-1421:50 ET | S-1 | Registration statement | 0001493152-22-016619 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:07 ET. Listed shows no prices and gives no investment advice.